< Back to situations

[ORGANIZATION]

Ibima Plataforma BIONAND

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [ES]

Moderna and Merck melanoma vaccine clinical trials

9 clusters · 443 sources · last updated

Latest: Moderna reports positive Phase III results for personalized cancer vaccine

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (also known as V940 or mRNA-4157), an experimental personalized mRNA cancer vaccine. The therapy is designed to target

Also covered in